UpHealth, Inc. financial data

Location
Delray Beach, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2024 - 06 Jun 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 72% % -2.3%
Debt-to-equity 261% % 81%
Return On Equity -34% % 74%
Return On Assets -9% % 83%
Operating Margin -83% % 18%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,932,192 shares 10%
Common Stock, Shares, Outstanding 18,811,398 shares
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 18,699,000 shares 19%
Weighted Average Number of Shares Outstanding, Diluted 18,699,000 shares 19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $105,311,000 USD -29%
Research and Development Expense $3,345,000 USD -53%
Selling and Marketing Expense $8,852,000 USD -41%
General and Administrative Expense $32,323,000 USD -32%
Operating Income (Loss) $87,909,000 USD 42%
Nonoperating Income (Expense) $36,648,000 USD 70%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $51,261,000 USD 77%
Income Tax Expense (Benefit) $3,301,000 USD
Net Income (Loss) Attributable to Parent $24,335,000 USD 89%
Earnings Per Share, Basic -1 USD/shares 90%
Earnings Per Share, Diluted -1 USD/shares 90%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $955,000 USD -93%
Assets, Current $171,906,000 USD 288%
Operating Lease, Right-of-Use Asset $344,000 USD -95%
Other Assets, Noncurrent $182,000 USD -62%
Assets $269,734,000 USD -20%
Accounts Payable, Current $3,739,000 USD -78%
Employee-related Liabilities, Current $6,309,000 USD 34%
Accrued Liabilities, Current $9,513,000 USD -77%
Liabilities, Current $145,526,000 USD 110%
Other Liabilities, Noncurrent $4,595,000 USD 2186%
Liabilities $187,949,000 USD -20%
Retained Earnings (Accumulated Deficit) $598,627,000 USD -4.2%
Stockholders' Equity Attributable to Parent $81,785,000 USD -20%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $81,785,000 USD -21%
Liabilities and Equity $269,734,000 USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $6,574,000 USD -63%
Net Cash Provided by (Used in) Financing Activities $635,000 USD -120%
Net Cash Provided by (Used in) Investing Activities $175,004,000 USD
Common Stock, Shares Authorized 300,000,000 shares
Common Stock, Shares, Issued 18,981,398 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $167,795,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $170,343,000 USD 1178%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,370,000 USD 3.8%
Deferred Tax Assets, Valuation Allowance $42,800,000 USD
Depreciation $6,300,000 USD -6%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $24,335,000 USD 88%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 46%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares
Unrecognized Tax Benefits $4,500,000 USD
Operating Lease, Payments $45,000 USD -89%
Additional Paid in Capital $697,410,000 USD 0.56%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $170,000 USD -71%
Share-based Payment Arrangement, Expense $900,000 USD -10%
Interest Expense $26,966,000 USD 2.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares